OpenAlex
PricingAboutJobs
Log inGet started
Work

A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Pain
DOI: 10.1097/j.pain.0000000000000363
Authors: Eugene R. Viscusi, Lynn Webster, Michael Kuss, Stephen Daniels, James A. Bolognese, Seth Zuckerman, David G. Soergel, Ruth Ann Subach, Emily Cook, Franck Skobieranda
Institutions: Thomas Jefferson University, Trevena, Inc. (United States), PRA Health Sciences, Premier Research Group, Cytel (United States)
Language: English

Topic: Pain Management and Opioid Use
Subfield: Anesthesiology and Pain Medicine
Field: Medicine
Domain: Health Sciences
Keywords: TRV130, biased ligands, mu-opioid receptor, G protein signaling, beta-arrestin, acute pain, bunionectomy, postoperative pain, morphine, intravenous analgesia, opioid adverse events, analgesic efficacy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2236862042
FWCI: 26.15
Cites: 36
Cited by: 237
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security